These seven U.S. and Canadian companies are scheduled to report their quarterly earnings today. Below is a preview of their key earning metrics, based on consensus estimates of analysts polled by Bloomberg. We have also provided analysts’ consensus buy ratings for these stocks with upside/downside potential for the upcoming 12-months.
| Company | Ticker | Exchange | Market Cap (MM) |
Last Price | Industry | Reporting Time |
Quarter | Sales ($MM) (Growth) |
Net Income ($MM) (Growth) |
EPS ($) (Growth) |
Total Analyst Coverage |
Buy Ratings | Upside Potential |
| Evoke Pharma Inc | EVOK | NASDAQ | 58.8 | 9.64 | Medical-Biomedical/Gene | AMC | 2Q 2014 | NA | -4.10 (NA) |
-0.68 (NA) |
3 | 100% | 304.6% |
| Gevo Inc | GEVO | NASDAQ | 87.0 | 1.27 | Energy-Alternate Sources | NA | 4Q 2013 | 1.46 (-24.4%) |
-14.50 (-10.0%) |
-0.32 (5.0%) |
6 | 67% | 224.1% |
| Cyclacel Pharmaceuticals Inc | CYCC | NASDAQ | 70.1 | 3.75 | Therapeutics | NA | 4Q 2013 | 0.13 (NA) |
-5.78 (NA) |
-0.36 (NA) |
3 | 100% | 157.8% |
| PEDEVCO Corp | PED | NYSE | 65.1 | 2.23 | Oil Comp-Explor&Prodtn | NA | 4Q 2013 | 0.77 (NA) |
NA | -0.01 (NA) |
2 | 100% | 99.6% |
| Legacy Oil + Gas Inc | LEG | TSX | 1,086.5 | 6.91 | Oil Comp-Explor&Prodtn | AMC | 4Q 2013 | 148.00 (52.4%) |
NA | 0.03 (200.0%) |
18 | 83% | 33.7% |
| Real Goods Solar Inc | RGSE | NASDAQ | 177.4 | 4.61 | Energy-Alternate Sources | AMC | 4Q 2013 | 33.45 (NA) |
-2.40 (NA) |
-0.06 (NA) |
3 | 100% | 8.5% |
| Neogen Corp | NEOG | NASDAQ | 1,658.7 | 45.32 | Veterinary Diagnostics | BMO | 3Q 2014 | 60.92 (19.3%) |
6.81 (2.4%) |
0.18 (0.0%) |
7 | 14% | -20.1% |
Source: Bloomberg
Note: Sales, Net Income & EPS are Bloomberg estimated figures and the growth rates mentioned are year-over-year.
BMO: Before Market Open
AMC: After Market Close
NA: Not Available
